MicroRNA-542 Promotes Mitochondrial Dysfunction and SMAD Activity and Is Elevated in Intensive Care Unit-acquired Weakness.

MLA

Garros, Roser Farre, et al. “MicroRNA-542 Promotes Mitochondrial Dysfunction and SMAD Activity and Is Elevated in Intensive Care Unit-Acquired Weakness.” American Journal of Respiratory & Critical Care Medicine, vol. 196, no. 11, Dec. 2017, pp. 1422–33. EBSCOhost, https://doi.org/10.1164/rccm.201701-0101OC.

APA

Garros, R. F., Paul, R., Connolly, M., Lewis, A., Garfield, B. E., Natanek, S. A., Bloch, S., Mouly, V., Griffiths, M. J., Polkey, M. I., & Kemp, P. R. (2017). MicroRNA-542 Promotes Mitochondrial Dysfunction and SMAD Activity and Is Elevated in Intensive Care Unit-acquired Weakness. American Journal of Respiratory & Critical Care Medicine, 196(11), 1422–1433. https://doi.org/10.1164/rccm.201701-0101OC

Chicago

Garros, Roser Farre, Richard Paul, Martin Connolly, Amy Lewis, Benjamin E. Garfield, S. Amanda Natanek, Susannah Bloch, et al. 2017. “MicroRNA-542 Promotes Mitochondrial Dysfunction and SMAD Activity and Is Elevated in Intensive Care Unit-Acquired Weakness.” American Journal of Respiratory & Critical Care Medicine 196 (11): 1422–33. doi:10.1164/rccm.201701-0101OC.